Results 281 to 290 of about 192,309 (409)

Therapeutic Errors Associated With Antithrombotic Medications Reported to United States Poison Centers

American Journal of Hematology, Volume 100, Issue 4, Page 561-574, April 2025.
ABSTRACT The objective of this study was to investigate the characteristics and trends of therapeutic errors in non‐healthcare facility settings associated with antithrombotic medications reported to United States Poison Centers by analyzing data from the National Poison Data System from 2000 to 2021.
Emma N. Cravo, Hannah L. Hays, Jaahnavi Badeti, Henry A. Spiller, Natalie I. Rine, Motao Zhu, Gary A. Smith   +6 more
wiley   +1 more source

A Case of Pulmonary Hemorrhage, Supratherapeutic International Normalized Ratio (INR), and Anti-neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis: Unmasking a Potential Link to Tirzepatide. [PDF]

Cureus
Shakour H, Mumtaz R, Feghali E, Abu-Samra AG.   +3 more
europepmc   +1 more source

Acute Renal Failure Due to Hypersensitivity Interstitial Nephritis Induced by Warfarin Sodium [PDF]

, 1989
Antonio Volpi, Giuseppina Ferrario, Flavio Giordano, G. Antiga, Graziana Battini, Carola Fabbri, Mietta Meroni, Anna Sessa   +7 more
openalex   +1 more source

Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches? [PDF]

, 2014
Al-Khatib, SM, Banerjee, A, Blendea, D, Camm, AJ, Conroy, JM, Cosio, FG, De Bono, J, G Cosio, MD, Guasch, E, Halperin, JL, Hess, PL, Kirchhof, P, Lip, GY, Nattel, S, Ruskin, J, Savelieva, I   +15 more
core   +1 more source

Glycated hemoglobin and body mass index as mediators of GLP‐1RAs and Alzheimer's disease and related dementias in patients with type 2 diabetes

Alzheimer's &Dementia, Volume 21, Issue 4, April 2025.
Abstract INTRODUCTION Whether reductions in glycated hemoglobin (HbA1c) levels and body mass index (BMI) mediate the association between glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and Alzheimer's disease and related dementias (ADRD) risk is unknown.
Huilin Tang, William T Donahoo, Steven T. DeKosky, Yao An Lee, Mikael Svensson, Jiang Bian, Jingchuan Guo   +6 more
wiley   +1 more source

Anticoagulation quality through time in therapeutic range in Sub-Saharan Africa: a systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Demsie DG, Addisu ZD, Tafere C, Feyisa K, Bahiru B, Yismaw MB, Mihret G, Tilahun A, Gebrie D, Berhe DF.   +9 more
europepmc   +1 more source

Drug-binding properties of rat α-foetoprotein. Specificities of the phenylbutazone-binding and warfarin-binding sites [PDF]

, 1986
Françoise Hervé, K.M. Rajkowski, Magali Martin, P Dessen, N. Cittanova   +4 more
openalex   +1 more source

Comparative effectiveness of direct oral anticoagulants and warfarin for the treatment of left ventricular thrombus

Journal of Thrombosis and Thrombolysis, 2019
M. E. Bass, T. Kiser, R. Page, C. McIlvennan, L. Allen, Garth Wright, C. Shakowski   +6 more
semanticscholar   +1 more source

Adherence and persistence with direct oral anticoagulants by dose regimen: A systematic review

British Journal of Clinical Pharmacology, Volume 91, Issue 4, Page 1096-1113, April 2025.
Introduction Direct oral anticoagulants (DOACs) are used in patients with non‐valvular atrial fibrillation (NVAF) to prevent complications such as embolic events. Poor adherence to DOACs increases the risk of these complications. This manuscript reviews the impact of once‐daily (OD) vs twice‐daily (BID) dosing regimens on adherence and persistence to ...
Raúl Quirós López, Francesc Formiga Pérez, Jan Beyer‐Westendorf   +2 more
wiley   +1 more source

The Efficacy and Safety of Direct Oral Anticoagulants Compared to Warfarin for Left Ventricular Thrombus Resolution. [PDF]

J Clin Med
Paiva MS, Gama F, Azevedo S, Lopes PM, Albuquerque F, Reis C, Freitas P, Guerreiro S, Abecasis J, Trabulo M, Ferreira AM, Ribeiras R, Ferreira J, Pulido Adragão P.   +13 more
europepmc   +1 more source